Are there new treatments being developed for hyperactivity in ADHD?

PostedAugust 25, 2025

UpdatedSeptember 5, 2025

ByMy Patient Advice

Author: Victoria Rowe, MSc | Reviewed by: Dr. Rebecca Fernandez, MBBS

Promising new treatments for ADHD are being developed, bringing hope for better management of hyperactivity and related symptoms. Researchers and clinicians are exploring emerging therapies, innovative approaches, and pharma developments that go beyond traditional stimulant medications. These advances aim to provide more personalised, effective, and well-tolerated options for both children and adults with ADHD.

Latest Innovations in ADHD Treatment

Here are some exciting new treatments and innovations in the pipeline for managing hyperactivity:

Non-Stimulant Medications

Pharma developments are producing new non-stimulant drugs that target different brain pathways, offering alternatives with fewer side effects.

Digital Therapeutics

Apps and video-game-based therapies designed to train focus and self-control are emerging as adjunct treatments approved in some regions.

Neurofeedback and Brain Stimulation

Techniques like EEG neurofeedback and transcranial magnetic stimulation (TMS) show promise in helping regulate brain activity and improve attention.

Behavioural Innovations

Emerging therapies incorporate mindfulness, biofeedback, and virtual reality to engage patients in managing hyperactivity more effectively.

Personalised Medicine

Researchers are working toward tailoring treatments based on genetics and brain imaging, improving outcomes by matching therapies to individual needs.

These emerging therapies reflect an exciting era of innovation in ADHD care. Visit providers like ADHD Certify for personal consultations and guidance on accessing the most current treatment options.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Hyperactivity.

Victoria Rowe, MSc

Author

Victoria Rowe is a health psychologist with a Master’s in Health Psychology and a BS in Applied Psychology. She has experience as a school psychologist, conducting behavioural assessments, developing individualized education plans (IEPs), and supporting children’s mental health. Dr. Rowe has contributed to peer-reviewed research on mental health, including studies on anxiety disorders and the impact of COVID-19 on healthcare systems. Skilled in SPSS, Minitab, and academic writing, she is committed to advancing psychological knowledge and promoting well-being through evidence-based practice.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Rebecca Fernandez, MBBS

Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy.